SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SCIO Scios Inc.
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
1477 17 0 SCIO
Emcee:  Rick Strange Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1402Monday September 10, 8:07 am Eastern Time Press Release SOURCE: Scios, Inc. ScioIRWIN JAMES FRANKEL-9/10/2001
1401Well, since the big announcement and rollout in August it's been straight doSkywatcher-9/4/2001
1400>>SUNNYVALE, Calif., Sept. 4 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO - netuck-9/4/2001
1399Scios Launches Natrecor in United StatesNew Drug Commercially Available in Ian@SI-8/22/2001
1398If that happens it would be a double within two years, from today's price - Gil Kempenich-8/16/2001
139708/14 09:09 Scios Inc. Reiterated `Buy' at Needham & Co. Ian@SI-8/14/2001
1396Prudential Sec reiterates Scios Inc. at Buy with $40 price targetIan@SI-8/13/2001
1395Nice Briefing.com coverage... Scios (SCIO) 20.76 +0.41: This small biopharmaceuIan@SI-8/13/2001
1394>>SUNNYVALE, Calif., Aug 13 (Reuters) - Small biotechnology company Scios tuck-8/13/2001
1393<<Scios Inc. Reports 2001 Second Quarter Financial Results Natrecor FDA PrLinda Pearson-7/26/2001
1392some snippets from a DJNewswire article on SCIO. I don't have a good URL, bIan@SI-7/24/2001
1391Scios Completes Pre-Approval Inspection for Natrecor SUNNYVALE, Calif., July 1Linda Pearson-7/19/2001
1390Nice round of imminent presentations should give SCIO an excellent marketing opIan@SI-7/10/2001
1389With Genetech's drug on the ropes, we are looking very good here...but with Skywatcher-7/10/2001
1388They said labeling was agreed upon and "excellent", only waiting for fXenaLives-7/10/2001
1387Just listening to the Conf Call Q&A. 129 Salespeople hired, more offers oIan@SI-7/10/2001
1386>>SUNNYVALE, Calif., July 10 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO - netuck-7/10/2001
1385Link to Advisory Committee meeting transcript: fda.govubrx-6/27/2001
1384We're rockin back with the BIO surge today....nice chrisSkywatcher-6/5/2001
1383No, I don’t think so. But, you did miss point from start: Message 15856112 <Miljenko Zuanic-5/30/2001
1382You have missed the point again. It is my position that IV NTG is rarely used inRobert Cohen-5/30/2001
1381<<I agree that NG may not be the universal standard of care, but it was whMiljenko Zuanic-5/30/2001
1380Robert, If the AC had been asked to approve NG based on the SCIO study what wouBiomaven-5/30/2001
1379Tyenol is also around for 50 years. Still, it does not stop hospital to charge 3Miljenko Zuanic-5/29/2001
1378It is cheap because it has been in use for over 25 years. The safety profile is Robert Cohen-5/29/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News